Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.

<Please explain how issuing a PR that states that the '336 has withstood yet ANOTHER attack would "impede, impair, frustrate or otherwise interfere with the activities of TPL in the execution of the commercialization program contemplated by the Commercialization Agreement".>

I never said it would. I agree with you that if there was a pr, it isn't likely to do any of those things, based on what we know. And that is the difficulty. There might actually be something we don't know. And perhaps PTSC may have the same concern. Even if nothing there, could TPL fabricate some justification? Is it worth a challenge which could seriously jepordize litigation with TPL?

<Only a very narrow and intentionally-harmful-towards-PTSC TPL perspective could justify keeping PTSC from issuing a PR on this issue based on that clause.>

I agree with the above statement FWIW.

Opty


Please login to post a reply
optymystic
City
Rank
President
Activity Points
18922
Rating
Your Rating
Date Joined
11/02/2006
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post